STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,334,418)	$ (2,310,246)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	56,699	133,450
Issuance of common stock, warrants and options for services	137,729	54,485
Modification of warrants issued for services	76,991	0
Employee option cost	510,278	966,585
Common stock contributed to 401 (k) plan	37,887	39,711
Impairment loss on abandonment of patents	240	10,223
Loss on retired equipment	0	2,011
Gain on derivative instruments	(1,610,817)	(2,746,198)
(Increase)/decrease in assets:
Receivables	28,384	143,714
Deferred rent	176,161	139,536
Prepaid expenses	(210,367)	471,936
Inventory used for R&D and manufacturing	(330,629)	247,585
Deposits	(200,000)	0
Increase/(decrease) in liabilities:
Accounts payable	(380,943)	(192,358)
Accrued expenses	232,905	23,252
Due to employees	(105,873)	20,843
Deferred rent liability	(749)	688
Net cash used in operating activities	(5,916,522)	(2,994,783)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of equipment	(8,587)	(16,093)
Expenditures for patent costs	0	(125)
Net cash used in investing activities	(8,587)	(16,218)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	19,380,190	9,807,375
Payments on oblgations under capital leases	2,665	1,025
Net cash provided by financing activities	19,377,525	9,806,350
NET INCREASE IN CASH AND CASH EQUIVALENTS	13,452,416	6,795,349
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	41,612	3,941,042
CASH AND CASH EQUIVALENTS, END OF PERIOD	13,494,028	10,736,391
ISSUANCE OF WARRANTS:
Increase in derivative liabilities	(7,321,071)	(4,200,000)
Decrease in additional paid-in capital	7,321,071	4,200,000
Total	0	0
ISSUANCE OF ADDITIONAL SHARES
Increase in common stock	(15,631)	0
Increase in additional paid-in capital	(1,101,786)	0
Decrease in additional paid-in capital	1,117,417	0
Total	0	0
ISSUANCE OF COMMON STOCK FOR PREPAID SERVICES:
Increase in additional paid-in capital	(55,362)	(236,165)
Increase in prepaid expenses	55,362	236,165
Total	0	0
PATENT COSTS INCLUDED IN ACCOUNTS PAYABLE
Increase in patent costs	9,208	8,641
Increase in accounts payable	(9,208)	(8,641)
Total	0	0
NON CASH RESEARCH AND OFFICE EQUIPMENT PURCHASES
Increase in research and office equipment	(12,126)	(36,622)
Increase in accounts payable	(2,664)	0
Increase in capital lease obligation	9,462	36,622
Total	0	0
CAPITAL LEASE PAYMENTS INCLUDED IN ACCOUNTS PAYABLE:
Decrease in capital lease obligation	26	1,105
Increase in accounts payable	(26)	(1,105)
Total	0	0
OFFERING COSTS INCLUDED IN ACCOUNTS PAYABLE:
Decrease additional paid-in capital	72,328	0
Increase in accounts payable	(72,328)	0
Total	0	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash expenditures for interest expense	$ 56,509	$ 41,878